Showing results (81-90 of 1,279) with videos related to
Sort By:
Pageof 128
Rheumatology (Oxford, England)|December 18, 2009
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafilDavid Launay, Olivier Sitbon, Jérôme Le Pavec, et al.Presse Medicale (Paris, France : 1983)|March 31, 2005
[Physiopathology of pulmonary arterial hypertension. Cellular and molecular aspects]Frédéric Perros, Marc HumbertNature Clinical Practice. Rheumatology|August 26, 2006
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseasesMarc Humbert, Gérald SimonneauCurrent Opinion in Pulmonary Medicine|August 3, 2020
An update on sarcoidosis-associated pulmonary hypertensionDebabrata Bandyopadhyay, Marc HumbertThe European Respiratory Journal|August 21, 2020
Targeting transforming growth factor-β receptors in pulmonary hypertensionChristophe Guignabert, Marc HumbertPresse Medicale (Paris, France : 1983)|February 6, 2021
Pulmonary arterial hypertension in systemic sclerosisBenoît Lechartier, Marc HumbertEuropean Respiratory Review : an Official Journal of the European Respiratory Society|December 2, 2016
Risk assessment in pulmonary arterial hypertensionAmresh Raina, Marc HumbertPresse Medicale (Paris, France : 1983)|January 14, 2010
[Neuropsychiatric manifestations in systemic sclerosis]David Launay, Thierry Baubet, Olivier Cottencin, et al.Presse Medicale (Paris, France : 1983)|December 24, 2014
[Angioedema: differential diagnosis]David LaunayFrontiers in Immunology|July 19, 2019
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature ReviewAmélie Leurs, Viviane Gnemmi, Arnaud Lionet, et al.Pageof 128